CLASS MEETING 27
RETROVIRUSES AND ONCOGENES
OVERVIEW
Oncogenic retrovirusea are great for molecular biologists -
they have packaged for our study the genes that cause cancer. The discovery
that cellular genes moved into retroviruses are responsible for transformation
was a revolution in the thinking about the disease and won the Nobel Prize
for Varmus and Bishop.
THE BASICS OF RETROVIRAL STRUCTURE
All oncogenic RNA viruses are retroviruses and all but one
are defective. Let's review defective viruses - they have lost the ability
to perform some function required for replication. In order for them to
replicate they must be co-infected with a helper virus that supplies this
function in trans.
The critical information for figuring out the mechanism by
which these viruses are oncogenic requires our knowing something about
their genome organization. Within the virion there are two copies of the
(+) RNA genome, held together by the cell-coded tRNAs that serve as primers
for reverse transcription (Fig. 27.1).
The retroviral genome is linear in the virion, and after conversion
to dsDNA, can integrate into the host cell's chromosomal DNA. As you all
know from the last test, the genome circularizes during replication. Here
is a diagram of how this happens (Fig.27
2). (You're not responsible for these details - this figure is inserted
to show how clever retroviruses are!)
Fig 27.3 shows the termini
of the integrated form, called the provirus, are different from the termini
of the provirus. The form in the provirus, direct repeats of sequences
call U3, R and U5, is call the long terminal repeat or LTR. There is a
promoter in R, that is one of strongest promoters known.
The genes of retroviruses fall into four groups, called gag,
pol
and
env, plus the regulatory genes. Fig 27.3 conains a diagram of their
locations on the (+) polarity, polyadenylated RNA. Gag stands for
group antigen - the proteins on the inside of the virus. The availability
of antibodies against these proteins allow them to be classified into groups,
hence the name.
Pol, not surprisingly, stands for the polymerase
or reverse transcriptase and env stands for the peoplomers or envelope
proteins.
Gag-pol is translated as a polyprotein, cleaved by protease
activity. Pol is not cleaved from gag until the encapsidation step, to
ensure that reverse transcriptase actually becomes a structural protein
and is available for the next round of replication. Env in produced from
the promoter in the LTR; it's mRNA is spliced and partially from a different
reading from gag-pol to avoid the gag-pol stop codon.
THE NON-DEFECTIVE ONCOGENIC RETROVIRUS - ROUS SARCOMA
VIRUS
Rous sarcoma virus was first isolated in about 1910 by Peyton
Rous who worked at the Rockefeller Institute. He did the classic experiment
--he was able to transfer production of a solid tumor, a sarcoma, from
one chicken to another, using a filtrate.
By the 1970s, scientists were investigating variants of Rous
sarcoma virus that we NOT oncogenic. What do you think caused them to lose
their ability to cause cancer?
To quote from a paper by M. Lai et al., 1970. PNAS 70:2266-2270.
We have found that the RNAs of sarcoma viruses contain most,
if not all, sequences present in transformation-deficient viruses. In addition,
sarcoma virus RNA contains some sequences that appear to be characteristic
of transforming ability for fibroblasts.
These results were obtained by a primitive method of sequenceing
RNA called "fingerprinting" - using enzymes to break the 32P-labeled
molecules into small pieces and electrophoresing them on paper using extremely
high voltage in huge tanks of pyridine - and believe me, that smelled wonderful
and was really healthy to be around!
What do you think the nature of these sequences was? The protein
coded by these sequences was called src (pronounced sark). How do you think
it was initially characterized?
What's odd about src is this it is phosphorylated on tyrosine,
and that it can autophosphorylate. This means that if the protein is mixed
with gamma-labeled ATP, the phosphate is transferred to a particular tyrosine
residue on the protein. The exciting thing about this observation is that
this phosphate can also be transferred to other proteins. What do you think
this transfer can do to the recipient protein?
WE HAVE MET THE ENEMY AND IT IS US (POGO)
The brilliant hypothesis of Harold Varmus (now Director of
the National Institutes of Health) and J. Michael Bishop concerned the
origin of the serc gene. They believed and confirmed that src was also
coded by the cellular genome. How do you think this was done - in 1976?
More important than the technical details was the revolution
this caused in thinking about cancers. If a cellular gene can cause
cauncer, then abberations of normal cellular metabolism can cause cancer
- hence the quote that introduces this section - which Bishop himself used.
HOW MANY ENEMIES?
Taking advantage of this way of thinking about cancer, virologists
began to look at the defective retroviruses. What do you think they found?
Yup - they found variants of normal cellular genes.
TERMINOLOGY NOTE:
Transforming genes in retroviruses are generically called viral
oncogenes or v-oncs or oncvs.
Their cellular homologs are called cellular oncogenes or proto-oncogenes
or c-oncs or onccs.
Where in the retroviral genome do you think these v-oncs are
located? They displace some of the normal genetic information of the retroviruses,
most often in the gag region. A "new" gene is generated by fusion of the
coding sequences for the viral protein and the coding sequences for the
proto-oncogene.
THIS IS IMPORTANT! The viral oncogene is created from
a normal cellular gene - not the other way around!
Table 27.1 shows many of
these oncogenes. Their proteins are designated as p (for protein) or gp
(for glycoprotein) or pp (for phosphoprotein) followed by a number that
gives their molecular weight in daltons x 10 -3 and a superscript
that identifies which normal viral gene is linked to which proto-oncogene.
Among the cellular genes that end up as v-oncs are genes for regulatory
proteins such as G protein (ras), transcription factors (myc, jun), and
anti-apoptosis factors (bcl-2).
The interesting thing about the v-oncs is that they have lost
the introns that are present in the c-oncs. Fig.
27.4 shows a model for how the v-oncs could be generated and how the
introns could be eliminated.
ANOTHER EFFECT OF RETROVIRUS INTEGRATION
One of the reasons that v-oncs are so deadly is that they are
transcribed from the LTR, which is one of the strongest promoters known.
Even retroviruses without transforming genes (called weakly transforming
retroviruses as opposed to acutely transforming retroviruses - those with
v-oncs) can potentially cause transformation. How do you think this occurs?
Remember that integration of retroviruses is random.
SUMMARY
All oncogenic RNA viruses are retroviruses and all but one
are defective. The non-defective retrovirus Rous sarcoma virus was shouwn
to contain an extra gene whose protein product, pp60src, is capable of
being pohsphorylated on a tyrosine reside and of transferring this phosphate
group to another protein. Eventually it was shown that the gene for src
was derived from a cellular gene. This led to the hypothesis that cancer
is not some bizarre disease, but an aberration or dis-regulation of normal
cellular metabolism.
Similar derivatives of cellular genes were sought in other
retroviruses. These were indeed found, but their inclusion in the virus
rendered it defective, requiring co-infection with a helper for replication.
In these viruses, the cellular genes are found as fusion proteins with
(usually) gag and their coding sequences lack introns. These cellular genes
include those for regulatory proteins and transcription factors.
Remember that retroviruses have one of the strongest promoters
know in their LTRs, that are generated during reverse transcription. This
means that the ongogenic proteins in retroviruses are produced at an extremely
high level. The integration of even a retrovirus without a v-onc can cause
transformation if the LTR activates a c-onc.